Implantable Drug Eluting Devices Market is expected to reach US$ 19.3 Billion by 2029 | FMI

The Global Implantable Drug Eluting Devices Market is expected to develop at a 6.0% CAGR from 2022 to 2029, with an estimated market value of roughly US$ 12.8 Billion in 2022. According to Future Market Insights, contraceptive medication-eluting devices will account for more than 39.8% of the global market in 2021. Remote-Controlled Chips and Programmable …

Global Keratitis Treatment Market to top US$ 789.89 million in 2023, Market to grow at a 6% CAGR until 2033: FMI Study

The global keratitis treatment market is predicted to exceed a remarkable worth of US$ 789.89 million in 2023, with a compound annual growth rate (CAGR) of 6% projected from 2023 to 2033. The increasing prevalence of contagious diseases is propelling the keratitis treatment market. As the heat increases, the disease becomes more prevalent. Furthermore, because …

Liver Fibrosis Treatment Market to surge at an 11% CAGR until 2033, reaching US$ 46.65 billion: FMI Study

The global liver fibrosis treatment market is anticipated to exceed a remarkable valuation of US$ 16.43 billion in 2023, with a compound annual growth rate (CAGR) of 11% projected from 2023 to 2033. The rising prevalence of undesirable outcomes such as hepatitis B or C virus infection, an impaired immune system due to co-infection with …

Surging Sales of Medical Protective Equipment Leading Manufacturers to Lift Up their Product Capacity: Industry Predicted to Rise at 9.5% CAGR

The global medical protective equipment market is predicted to register a CAGR of 9.5% over the forecast period, according to FMI’s analysis. The industry’s value is anticipated to increase from US$ 21.3 billion in 2023 to US$ 52.8 billion by 2033 end. The medical protective equipment market is being driven by the surging demand from …

Leukocyte Adhesion Deficiency Market is projected to reach US$ 15.2 billion by 2033, Hematopoietic Stem Cell Transplantation to Generate 38% Revenue: FMI

The global leukocyte adhesion deficiency management market is expected to reach a valuation of US$ 8.09 billion in 2023 and is projected to reach US$ 15.2 billion by 2033, trailing a CAGR of 6.51% during the forecast period.  Surging number of research and development activities for improving the effectiveness of immunodeficiency therapeutics is expected to …

Global Opioid Use Disorder Treatment Market Size to reach US$ 8.4 billion by 2033, Buprenorphine to account for 81.4% of all Treatments: FMI Study

The global opioid use disorder treatment market size is expected to attain an impressive valuation of US$ 3.07 billion in 2023 and is projected to reach US$ 8.4 billion by 2033, expanding at a CAGR of 10.5% during the forecast period. The drug abuse treatment providers and manufacturers primarily focus on creating awareness among people …

Nasal Polyposis Treatment Market to reach US$ 8.8 billion by 2033, Corticosteroids to Constitute 55% of all Treatments: FMI Report

in value terms by 2023-end and is projected to rise at a CAGR of 6.7% until 2033, according to a recently published report by Future Market Insights. By the end of the said forecast period, a valuation of US$ 8.8 billion is expected for the market. A growing geriatric population suffering from chronic rhinosinusitis, with …

Point-Of-Care Molecular Diagnostics Market is expected to reach US$ 11 Billion by 2032

The global point-of-care molecular diagnostics market was estimated to be worth US$ 3 billion in 2021 and is expected to grow at a robust CAGR of 8% between 2022 and 2032, reaching around US$ 11 billion by 2032. The rising prevalence of infectious diseases and cancer worldwide, as well as growing end user preference for …

Epilepsy Monitoring Devices Market is expected to reach US$ 838 Billion by 2032

According to a Future Market Insights exclusive report, the global epilepsy monitoring devices market is expected to grow at a 5% CAGR to US$ 838 Billion by 2032, up from US$ 490 Million in 2021. The rising incidence and prevalence of epilepsy, rising preference for ambulatory healthcare and wearables, rising demand for epilepsy monitoring devices, …

Infertility Treatment Market expected to reach valuation of US$ 3.5 Billion by 2032

The global infertility treatment market was worth US$ 1.5 billion in 2021 and is expected to grow at an 8% CAGR between 2022 and 2032, surpassing a valuation of US$ 3.5 billion by the end of 2032. Rising infertility rates around the world, as well as the growing popularity of advanced infertility treatments such as …